Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate.

Publication

Citation
Press NJ, Taylor RJ, Fullerton JD, Tranter P, McCarthy C, Keller TH, Arnold N, Beer D, Brown L, Cheung R, Christie J, Denholm A, Haberthuer S, Hatto JD, Keenan M, Mercer MK, Oakman H, Sahri H, Tuffnell AR, Tweed M, Tyler JW, Wagner T, Fozard JR, Trifilieff A.: Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate. J Med Chem, Volume 55 (17), 2012
Authors
Arnold N, Beer D, Brown L, Cheung R, Christie J, Denholm A, Fozard JR, Fullerton JD, Haberthuer S, Hatto JD, Keenan M, Keller TH, McCarthy C, Mercer MK, Oakman H, Press NJ, Sahri H, Taylor RJ, Tranter P, Trifilieff A., Tuffnell AR, Tweed M, Tyler JW, Wagner T
Journal
J Med Chem
Year
2012
PubMed
22889281
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc
Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate. | MolMeDB